Unexpected effects of voluntary exercise training on natriuretic peptide and receptor mRNA expression in the ob/ob mouse heart

Regulatory Peptides

Volumn 188, Issue , 2014, Pages 52-59

  Broderick, Tom L ^a   Wang, Donghao ^b   Jankowski, Marek ^b   Gutkowska, Jolanta ^b  

^a MIDWESTERN UNIVERSITY   (United States)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Glucose; Natriuretic peptides; Ob ob; Obesity; Oxytocin; Running

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; GLUCOSE; MESSENGER RNA; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE RECEPTOR C; NATRIURETIC PEPTIDE TYPE C; OXYTOCIN RECEPTOR; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DOWN REGULATION; EXERCISE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; INSULIN RESISTANCE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RUNNING; SITTING; TREADMILL EXERCISE; TRIACYLGLYCEROL BLOOD LEVEL;

GLUCOSE; NATRIURETIC PEPTIDES; OB/OB; OBESITY; OXYTOCIN; RUNNING;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; BODY WEIGHT; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION; GLUCOSE TRANSPORTER TYPE 4; MALE; MICE; MICE, OBESE; MOTOR ACTIVITY; MYOCARDIUM; NATRIURETIC PEPTIDES; PHYSICAL CONDITIONING, ANIMAL; RECEPTORS, OXYTOCIN; RNA, MESSENGER; RUNNING;

EID: 84891928378     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2013.12.005     Document Type: Article

References (36)

1. Bakos J., Hlavacova N., Makatsori A., Tybitanclova K., Zorad S., Hinghofer-Szalkay H., Johansson B.B., Jezova D. Oxytocin levels in the posterior pituitary and in heart are modified by voluntary wheel running. Regul Pept 2007, 139:96-101.
2. Barouch L.A., Gao D., Chen L., Miller K.L., Xu W., Phan A.C., Kittleson M.M., Minhas K.M., Berkowitz D.E., Wei C., Hare J.M. Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circ Res 2006, 98:119-124.
3. Barouch L.A., Berkowitz D.E., Harrison R.W., O'Donnell C.P., Hare J.M. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 2013, 108:754-759.
4. Bartells E.D., Nielson J.M., Bisgaard L.S., Goetze J.P., Nielsen E.D. Decreased expression of natriuretic peptides associated with lipid accumulation in cardiac ventricle of obese mice. Endocrinology 2010, 151:5218-5225.
5. Bartels E.D., Nielsen J.M., Bisgaard L.S., Goetze J.P., Nielsen L.B. Decreased expression of natriuretic peptides associated with lipid accumulation in cardiac ventricle of obese mice. Endocrinology 2010, 151:5218-5225.
6. Boule N.G., Haddad E., Kenny G.P., Wells G.A., Sigal R.J. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 2011, 286:1218-1227.
7. Broderick T.L., Parrott C.R., Wang D., Jankowski M., Gutkowska J. Expression of GATA4 and downstream genes after exercise training in the db/db mouse. Pathophysiology 2012, 19:193-203.
8. Broderick T.L., Jankowski M., Wang D., Danalache B.A., Parrott C.R., Gutkowska J. Downregulation in GATA4 and downstream structural and contractile genes in the db/db mouse heart. ISRN Endocrinol 2012, 10.5402/2012/736860.
9. Christoffersen C., Bartels S.D., Nielsen L.B. Heart specific up-regulation of genes for B-type and C-type natriuretic peptide receptors in diabetic mice. Eur J Clin Invest 2006, 36:69-75.
10. Cortez M.Y., Torgan C.E., Brozinick J.T., Ivy J.L. Insulin resistance of obese Zucker rats exercise trained at two different intensities. Am J Physiol Endocrinol Metab 1991, 261:E613-E619.
11. Davidoff A.J., Mason M.M., Davidson M.B., Carmody M.W., Hintz K.K., Wold L.E., Podolin D.A., Ren J. Sucrose-induced cardiomyocyte dysfunction is both preventable and reversible with clinically relevant treatments. Am J Physiol Endocrinol Metab 2004, 286:E718-E724.
12. Diabetes Prevention Program Research Group Reduction of the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.
13. Esser K.A., Su W., Matveev S., Wong V., Zeng L., McCarthy J.J., Smart E.J., Guo Z., Gong M.C. Voluntary wheel running ameliorates vascular smooth muscle hyper-contractility in type 2 diabetic db/db mice. Appl Physiol Nutr Metab 2007, 32:711-720.
14. Florian M., Jankowski M., Gutkowska J. Oxytocin increases glucose uptake in neonatal cardiomyocytes. Endocrinology 2010, 151:482-491.
15. Gutkowska J., Jankowski M., Mukaddam-Daher S., McCann S.M. Oxytocin is a cardiovascular hormone. Braz J Med Biol Res 2000, 33:625-633.
16. Gutkowska J., Paquette A., Wang D., Lavoie J.M., Jankowski M. Effect of exercise training on cardiac oxytocin and natriuretic peptide systems in ovariectomized rats. Am J Physiol Regul Integr Comp Physiol 2007, 293:R267-R275.
17. Gutkowska J., Broderick T.L., Bogdan D., Wang D., Lavoie J.M., Jankowski M. Downregulation of oxytocin and natriuretic peptides in diabetes: possible implications in cardiomyopathy. J Physiol 2009, 587:4725-4736.
18. Hubinger A., Franzen A., Gries F.A. Hormonal and metabolic response to physical exercise in hyperinsulinemic and non-hyperinsulinemic type 2 diabetics. Diabetes Res 1987, 4:57-61.
19. Kelley D.E., Goodpaster B.H. Effects of exercise on glucose homeostasis in Type 2 diabetes mellitus. Med Sci Sports Exerc 2001, 33:S495-S501.
20. Kjaer M., Hollenbeck C.B., Frey-Hewitt B., Galbo H., Haskell W., Reaven G.M. Glucoregulation and hormonal responses to maximal exercise in non-insulin-dependent diabetes. J Appl Physiol 1990, 68:2067-2074.
21. Kobayashi S., Mao K., Zheng H., Wang X., Patterson C., O'connell T.D., Liang Q. Diminished GATA4 protein levels contribute to hyperglycemia-induced cardiomyocyte injury. J Biol Chem 2007, 282:21945-21952.
22. Kuhn M. Molecular physiology of natriuretic peptide signalling. Basic Res Cardiol 2004, 99:76-82.
23. Mascareno E., Beckles D., Dhar-Mascareno M., Siddiqui M.A.Q. Enhanced hypertrophy in ob/ob mice due to impairment in expression of atrial natriuretic peptide. Vascul Pharmacol 2009, 51:198-204.
24. Meek T.H., Dlugosz E.M., Vu K.T., Garland T. Effects of leptin treatment and Western diet on wheel running in selectively bred high runner mice. Physiol Behav 2012, 106:252-258.
25. Moien A.F., Khazaei M., Ghosh S., Rahman M.M., Sallam N., Laher I. Exercise restores coronary vascular function independent of myogenic tone or hyperglycemic status in db/db mice. Am J Physiol Heart Circ Physiol 2008, 295:H1470-H1480.
26. Morton G.J., Kaiyala K.J., Fisher J.D., Ogimoto K., Schwartz M.W., Wisse B.E. Identification of a physiological role for leptin in the regulation of ambulatory activity and wheel running in mice. Am J Physiol Endocrinol Metab 2011, 300:E392-E401.
27. Molkentin J.D. The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem 2000, 275:38949-38952.
28. Parrott C.R., Ghosh P., Tedeschi J., Gunasekara G., Broderick T.L. Urinary corticosterone and normetanephrine levels after voluntary and forced treadmill running in the db/db mouse. J Diabetes Mell 2011, 1(40):71-78. 10.4236/jdm.2011.14011.
29. Podolin D.A., Wei Y., Pagliassotti M.J. Effects of a high-fat diet and voluntary wheel running on gluconeogenesis and lipolysis in rats. J Appl Physiol 1999, 86:1374-1380.
30. Roden M., Ludwig C., Nowotny P., Schneider B., Clodi M., Vierhapper H., Roden A., Waldhausl W. Relative hypoleptinemia in patients with type 1 and type 2 diabetes mellitus. Int J Obes 2000, 24:976-981.
31. Rosmond R. Stress induced disturbances of the HPA axis: a pathway to Type 2 diabetes?. Med Sci Monit 2003, 9:RA35-RA39.
32. Sennott J., Morrissey J., Standley P.R., Broderick T.L. Treadmill exercise fails to reverse defects in glucose, insulin and muscle GLUT4 content in the db/db mouse model of diabetes. Pathophysiology 2008, 15:173-179.
33. Taylor J.A., Christenson R.H., Rao K., Jorge M., Gottlieb S.S. B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. Am Heart J 2006, 152:1071-1076.
34. Temsah R., Nemer M. GATA factors and transcriptional regulation of cardiac natriuretic peptide genes. Regul Pept 2005, 128:177-185.
35. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., Keinanen-Kiukaanniemi S., Laakso M., Louheranta A., Rastas M., Salminen V., Uusitupa M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350.
36. Woods R.L. Cardioprotective functions of atrial natriuretic peptide and B-type natriuretic peptide: a brief review. Clin Exp Pharmacol Physiol 2004, 31:791-794.